ConductScience.org, home

Paper4855751

Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate.

Kann HE and 2 others. Cancer Res, 1974. Cited by 116 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate. Papers, record 4855751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4855751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate.
PubMed
Journal
Cancer Res
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
4.75
iCite
Revised in PubMed
2019-12-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kann HE JrH E
2Kohn KWK W
3Lyles JMJ M

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarmustineMajor topic
CyanatesMajor topic
DNA RepairMajor topic
DNA, NeoplasmMajor topic
Leukemia L1210Major topic
Mustard CompoundsMajor topic
Radiation EffectsMajor topic
Animals
Cells, Cultured
Cycloheximide
DNA, Single-Stranded
Dactinomycin
Depression, Chemical
Ethylamines
Hydroxyurea
Isocyanates
Mice

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
38179340Continuous Extraction of 2-Chloroethyl isocyanate for 1-(2-chloroethyl)-3-cyclohexylurea Purification.Chem Eng Process2023https://conductscience.org/library/papers/38179340PubMed
25068797Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death.PLoS One2014https://conductscience.org/library/papers/25068797PubMed
19026985Inhibition of human DNA polymerase beta activity by the anticancer prodrug Cloretazine.Biochem Biophys Res Commun2009https://conductscience.org/library/papers/19026985PubMed
6928639DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6928639PubMed
6678867The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.Invest New Drugs1983https://conductscience.org/library/papers/6678867PubMed
6088716Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines.J Neurooncol1983https://conductscience.org/library/papers/6088716PubMed
2564000H2-antagonists and carmustine.J Cancer Res Clin Oncol1989https://conductscience.org/library/papers/2564000PubMed
2191847Antineoplastic drugs in 1990. A review (Part II).Drugs1990https://conductscience.org/library/papers/2191847PubMed
2052560Selective activation of human heat shock gene transcription by nitrosourea antitumor drugs mediated by isocyanate-induced damage and activation of heat shock transcription factor.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/2052560PubMed
502351[Effect of BCNU on glutathione metabolism in human blood cells].Klin Wochenschr1979https://conductscience.org/library/papers/502351PubMed
479266The effects of 1-methyl-1-nitrosourea on the survival pattern of cycling and noncycling HeLa cells.J Cancer Res Clin Oncol1979https://conductscience.org/library/papers/479266PubMed
393428Mutagenic effects of some anticancer antibiotics.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/393428PubMed
195411The combined modality approach in the treatment of inoperable small-cell anaplastic carcinoma of the lung.Z Krebsforsch Klin Onkol Cancer Res Clin Oncol1977https://conductscience.org/library/papers/195411PubMed
136102
Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol1976https://conductscience.org/library/papers/136102PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4855751

GET https://conductscience.org/api/papers/v1/4855751/authors